Tinea corporis and cruris are typically treated with topical azoles or terbinafine, to which T. indotineae is often resistant 2, 3 Oral fluconazole or terbinafine are also commonly ineffective. 3 ...
Anaplasmosis is the second most common tick-borne disease in Canada, with rapidly rising incidence owing to the expanding ...
Background: We undertook research to improve the AGREE instrument, a tool used to evaluate guidelines. We tested a new seven-point scale, evaluated the usefulness of the original items in the ...
Pulmonary embolism (PE) occurs when a venous thrombus becomes lodged in lung arteries, causing impairment in oxygenation, ...
Earn CPD Credits This article is eligible for 1.0 Mainpro+ credits. Did you read this article? Mainpro+ credits will be transferred automatically for members of the College of Family Physicians of ...
An α-2 adrenergic agonist approved only for veterinary use, medetomidine is similar to xylazine, but substantially more ...
A 40-year-old man emigrated from India 2 years ago and has no prior medical conditions. He requested a clinic visit with his ...
CMA Members: If you're currently receiving a print copy and would like to change your address, or if you would like to be added to or removed from the distribution list, please contact the Engagement ...
Background: Canada has achieved near-universal adoption of electronic health records (EHRs) and yet interoperability, the secure exchange and use of health data across different systems and settings, ...
Up to 0.3% of males will receive a diagnosis of anorexia nervosa in their lifetime.1 Affected males have a 6-times higher mortality rate than those in the general population. 2 Stigma, poor mental ...
Chronic spontaneous urticaria affects 1% to 3% of people It is not an allergy and carries no risk of anaphylaxis, but is a chronic type 2 inflammatory disease driven by autoimmune mast cell activation ...
Common approaches include a 1-time intravenous (IV) dose of 7.5 to 10 mg/kg (ideal body weight) or smaller doses of, for example, 130 mg IV every 30 minutes until the patient is lightly sedated.3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results